Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Global Forecast to 2030

1.    Market Definition & Scope
       1.1.    Market Definition
       1.2.    Market Ecosystem
       1.3.    Currency & Limitations
       1.4.    Key Stakeholders
2.    Research Methodology
       2.1.    Research Approach
       2.2.    Process of Data Collection and Validation
                 2.2.1.    Secondary Research
                 2.2.2.    Primary Research/Interviews with Key Opinion Leaders from the Industry
       2.3.    Market Sizing and Forecasting
                 2.3.1.    Market Size Estimation Approach
                 2.3.2.    Growth Forecast Approach
       2.4.    Assumptions for the Study
3.    Executive Summary
4.    Market Insights
       4.1.    Overview
       4.2.    Factors Affecting Market Growth
                 4.2.1.    Impact Analysis of Market Dynamics
       4.3.    Direct-to-consumer Laboratory Testing Market: Regulatory Analysis
                 4.3.1.    Overview
                 4.3.2.    North America
                              4.3.2.1.    U.S.
                              4.3.2.2.    Canada
                 4.3.3.    Europe
                 4.3.4.    Asia-Pacific
                              4.3.4.1.    China
                              4.3.4.2.    Japan
                              4.3.4.3.    India
                 4.3.5.    Latin America
                 4.3.6.    Middle East
       4.4.    Direct-to-consumer Laboratory Testing Market: Pricing Analysis
       4.5.    Case Studies
                 4.5.1.    DTC Genetic Testing Companies Adapting to the Industry Slowdown
       4.6.    Industry Trends
                 4.6.1.    Declining Costs of Sequencing to Make DTC Genetic Testing More Accessible
                 4.6.2.    Shift from Physician-driven to Consumer-driven Healthcare
5.    Direct-to-consumer Laboratory Testing Market Assessment—by Application
       5.1.    Overview
       5.2.    Genetic Testing
                 5.2.1.    Ancestry/Genealogy
                 5.2.2.    Disease Risk Assessment
                              5.2.2.1.    Cancer
                              5.2.2.2.    Cardiovascular Diseases
                              5.2.2.3.    Neurological Diseases
                              5.2.2.4.    Other Diseases
                 5.2.3.    Carrier Status
                 5.2.4.    Other Genetic Tests
       5.3.    Diabetes Testing
       5.4.    Routine Clinical Testing
       5.5.    Thyroid Function Testing
       5.6.    COVID-19 Testing
       5.7.    Sexually Transmitted Disease Testing
       5.8.    Other Applications
6.    Direct-to-consumer Laboratory Testing Market Assessment—by Sample Type    
       6.1.    Overview
       6.2.    Blood
       6.3.    Saliva
       6.4.    Urine
       6.5.    Other Samples
7.    Direct-to-consumer Laboratory Testing Market Assessment—by Geography
       7.1.    Overview
       7.2.    North America
                 7.2.1.    U.S.
                 7.2.2.    Canada
       7.3.    Europe
                 7.3.1.    U.K.
                 7.3.2.    Germany
                 7.3.3.    Italy
                 7.3.4.    France
                 7.3.5.    Spain
                 7.3.6.    Rest of Europe (RoE)
       7.4.    Asia-Pacific
                 7.4.1.    China
                 7.4.2.    Japan
                 7.4.3.    India
                 7.4.4.    Rest of Asia-Pacific (RoAPAC)
       7.5.    Latin America
       7.6.    Middle East & Africa
8.    Competition Analysis
       8.1.    Overview
       8.2.    Key Growth Strategies
       8.3.    Competitive Dashboard
                 8.3.1.    Industry Leaders
                 8.3.2.    Market Differentiators
                 8.3.3.    Vanguards
                 8.3.4.    Emerging Companies
       8.4.    Vendor Benchmarking
       8.5.    Market Share Analysis (2022)
                 8.5.1.    Ancestry.com, LLC (U.S.)
                 8.5.2.    Laboratory Corporation of America Holdings (U.S.)
                 8.5.3.    23andMe Holding Co. (U.S.)
                 8.5.4.    Quest Diagnostics Incorporated (U.S.)
9.    Company Profiles
       9.1.    Quest Diagnostics Incorporated
       9.2.    Laboratory Corporation of America Holdings
       9.3.    23andMe Holding Co.
       9.4.    Myriad Genetics, Inc.
       9.5.    Everlywell, Inc. (A Subsidiary of Everly Health, Inc.)
       9.6.    DirectLabs, LLC
       9.7.    Ancestry.com, LLC
       9.8.    MyMedLab, Inc.
       9.9.    ANY LAB TEST NOW
       9.10.    Thorne Healthtech, Inc.
       9.11.    LetsGetChecked, Inc.
       9.12.    Other Companies
10.    Appendix
         10.1.    Available Customization
         10.2.    Related Reports

List of Tables
Table 1    Europe: Some of the Countries Requiring Medical Supervision for Genetic Testing
Table 2    Price Comparison: DTC Laboratory Tests Vs. Conventional Laboratory Tests (USD)
Table 3    DTC Genetic Testing: Pricing Analysis
Table 4    Global Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 5    Difference Between Conventional Genetic Testing and DTC Genetic Testing
Table 6    Global Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 7    Global Direct-to-consumer Genetic Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 8    Global DTC Genetic Testing Market for Ancestry/Genealogy, by Country/Region, 2021–2030 (USD Million)
Table 9    Global DTC Genetic Testing Market for Diseases Risk Assessment, by Type, 2021–2030 (USD Million)
Table 10    Global DTC Genetic Testing Market for Diseases Risk Assessment, by Country/Region, 2021–2030 (USD Million)
Table 11    Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
Table 12    Global Disease Risk Assessment Testing Market for Cancer, by Country/Region, 2021–2030 (USD Million)
Table 13    Global Disease Risk Assessment Testing Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 14    Burden of Neurological Conditions (DALYs Per 100,000 Population)
Table 15    Global Disease Risk Assessment Testing Market for Neurological Diseases, by Country/Region, 2021–2030 (USD Million)
Table 16    Incidence of Common Genetic Disorders
Table 17    Global Disease Risk Assessment Testing Market for Other Diseases, by Country/Region, 2021–2030 (USD Million)
Table 18    Global DTC Genetic Testing Market for Carrier Status, by Country/Region, 2021–2030 (USD Million)
Table 19    Global DTC Genetic Testing Market for Other Genetic Tests, by Country/Region, 2021–2030 (USD Million)
Table 20    Number of People with Diabetes, by Region (2021 Vs. 2030) (In Thousands)
Table 21    Global DTC Diabetes Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 22    Commonly Performed Routine Clinical Testing
Table 23    Global DTC Routine Clinical Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 24    Commonly Tests Included in a Thyroid Panel
Table 25    Global DTC Thyroid Function Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 26    COVID-19 Cases & Deaths, by Region (As of 12th March 2023)
Table 27    Global Direct-to-consumer Laboratory Testing Market for COVID-19 Testing, by Country/Region, 2021–2030 (USD Million)
Table 28    HIV Statistics (2021)
Table 29    Global Direct-to-consumer Laboratory Testing Market for Sexually Transmitted Diseases, by Country/Region, 2021–2030 (USD Million)
Table 30    Commonly Performed DTC Tests for Other Applications
Table 31    Global Direct-to-consumer Laboratory Testing Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 32    Global Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 33    Global Direct-to-consumer Laboratory Testing Market for Blood, by Country/Region, 2021–2030 (USD Million)
Table 34    Global Direct-to-consumer Laboratory Testing Market for Saliva, by Country/Region, 2021–2030 (USD Million)
Table 35    Reason for Conducting a Urine Test
Table 36    Global Direct-to-consumer Laboratory Testing Market for Urine, by Country/Region, 2021–2030 (USD Million)
Table 37    Sample Type for Various Test
Table 38    Global Direct-to-consumer Laboratory Testing Market for Other Samples, by Country/Region, 2021–2030 (USD Million)
Table 39    Global Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 40    North America: Direct-to-consumer Laboratory Testing Market, by Country, 2021–2030 (USD Million)
Table 41    North America: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 42    North America: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 43    North America: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 44    North America: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 45    Price Comparison of Traditional Laboratory Testing Vs. DTC Laboratory Testing in the U.S.
Table 46    U.S.: Key Macro & Micro Indicators
Table 47    U.S.: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 48    U.S.: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 49    U.S.: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 50    U.S.: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 51    Canada: Key Macro Indicators
Table 52    Canada: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 53    Canada: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 54    Canada: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 55    Canada: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 56    Europe: Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 57    Europe: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 58    Europe: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 59    Europe: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 60    Europe: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 61    U.K.: Prevalence of Various Chronic Conditions
Table 62    U.K.: Key Macro Indicators
Table 63    U.K.: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 64    U.K.: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 65    U.K.: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 66    U.K.: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 67    Germany: Key Macro Indicators
Table 68    Germany: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 69    Germany: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 70    Germany: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 71    Germany: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 72    Italy: Key Macro Indicators
Table 73    Italy: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 74    Italy: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 75    Italy: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 76    Italy: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 77    France: Key Macro Indicators
Table 78    France: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 79    France: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 80    France: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 81    France: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 82    Spain: Key Macro Indicators
Table 83    Spain: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 84    Spain: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 85    Spain: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 86    Spain: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 87    Rest of Europe: Percent of Elderly Population (2012 Vs. 2021 Vs. 2022)
Table 88    Rest of Europe: Cancer Statistics (2020 Vs. 2030)
Table 89    Rest of Europe: Diabetes Statistics (2021 Vs. 2030) (In Thousands)
Table 90    Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 91    Rest of Europe: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 92    Rest of Europe: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 93    Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 94    Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 95    Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 96    Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 97    Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 98    Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 99    China: Some of the Direct-to-consumer Genetic Testing Products Comparison
Table 100    China: Key Macro Indicators
Table 101    China: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 102    China: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 103    China: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 104    China: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 105    Japan: Key Macro Indicators
Table 106    Japan: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 107    Japan: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 108    Japan: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 109    Japan: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 110    India: Key Trends in the Direct-to-consumer Laboratory Testing Market
Table 111    India: Key Macro Indicators
Table 112    India: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 113    India: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 114    India: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 115    India: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 116    Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 117    Rest of Asia-Pacific: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 118    Rest of Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 119    Rest of Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 120    Rest of Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 121    Rest of Asia-Pacific: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 122    Latin America: Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 123    Latin America: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 124    Latin America: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 125    Latin America: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 126    Latin America: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 127    Latin America: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 128    Middle East & Africa: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 129    Middle East & Africa: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 130    Middle East & Africa: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)    
Table 131    Middle East & Africa: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 132    Recent Developments, by Company, 2020–2023

List of Figures
Figure 1    Research Process
Figure 2    Secondary Sources Referenced for this Study
Figure 3    Primary Research Techniques
Figure 4    Key Executives Interviewed
Figure 5    Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6    Market Sizing and Growth Forecast Approach
Figure 7    Global Direct-to-consumer Laboratory Testing Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 8    Global Direct-to-consumer Laboratory Testing Market Size, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 9    Direct-to-consumer Laboratory Testing Market Size, by Geography
Figure 10    U.S.: Regulations for DTC Laboratory Testing
Figure 11    Types of Direct-to-consumer Tests and Their Regulatory Pathways
Figure 12    Genome Sequencing Costs, 2010–2021 (USD)
Figure 13    Global Direct-to-consumer Laboratory Testing Market, by Application, 2023–2030 (USD Million)
Figure 14    Process of DTC Genetic Testing
Figure 15    Estimated Number of New Cancer Cases (2020–2040)
Figure 16    Global Direct-to-consumer Laboratory Testing Market, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 17    Benefits of Saliva Sampling
Figure 18    Global Direct-to-consumer Laboratory Testing Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 19    North America: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 20    U.S.: Disposable Personal Income (USD Billion)
Figure 21    Europe: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 22    U.K.: Number of New Sexually Transmitted Infections Diagnosed Per 100,000 Population
Figure 23    Italy: Percentage of Population Aged 65 & Above
Figure 24    Spain: Number of People Living with HIV (2010-2021)
Figure 25    Asia-Pacific: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 26    Japan: Percentage of Population Aged 65 and Above (2010–2030)
Figure 27    Brazil: Number of People with Diabetes (In Thousands)
Figure 28    Argentina: HIV Statistics
Figure 29    Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 30    Competitive Dashboard: Direct-to-consumer Laboratory Testing Market
Figure 31    Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Application
Figure 32    Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Region
Figure 33    Global Direct-to-consumer Laboratory Testing Market Share Analysis, by Key Players, 2022 (%)
Figure 34    Quest Diagnostics Incorporated.: Financial Overview (2022)
Figure 35    Laboratory Corporation of America Holdings: Financial Overview (2022)
Figure 36    23andMe Holding Co.: Financial Overview (2021)
Figure 37    Myraid Genetics, Inc: Financial Overview (2022)
Figure 38    Thorne Healthtech, Inc.: Financial Overview (2022)